| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 11, 2017HRS Late-Breaking Trial Reveals High Implant Success Rate and Low Early Major Complication Rate for the Medtronic Micra® Transcatheter Pacing System (TPS)
DUBLIN and CHICAGO - May 11, 2017 - Medtronic plc (NYSE: MDT) today announced preliminary results for the Medtronic Micra® Transcatheter Pacing System (TPS) Post-Approval Registry, revealing a...
-
May 10, 2017Portfolio of Next Generation Heart Failure Devices Offers Effective Pacing and Access to the Most Advanced Diagnostic Imaging Procedures
DUBLIN - May 10, 2017 - Medtronic plc (NYSE:MDT) has received U.S. Food and Drug Administration (FDA) approval for a portfolio of quadripolar cardiac resynchronization therapy-pacemakers (CRT-Ps)...
-
May 9, 2017
DUBLIN - May 9, 2017 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for the fourth quarter and fiscal year 2017 on Thursday, May 25, 2017. A news release will be...
-
May 1, 2017Engineered for Exceptional Deliverability, Advanced DES Technology Features Thinner Struts, Enhanced Visibility and the Broadest Size Matrix in the U.S.
DUBLIN – May 1, 2017 – Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Resolute Onyx™ Drug-Eluting Stent (DES). The...
-
Apr 26, 2017Presented at Charing Cross, Five-Year Clinical Data from Global ENGAGE Registry Support Endurant II's Market-Leading Position Worldwide
DUBLIN and LONDON - April 26, 2017 - Medtronic plc (NYSE:MDT) today reported its Endurant® II abdominal aortic aneurysm (AAA) stent graft system continues to demonstrate long-term durability and...